Where Tandem Diabetes Care Stands With Analysts
Portfolio Pulse from Benzinga Insights
Tandem Diabetes Care (NASDAQ:TNDM) has received mixed analyst ratings in the last quarter, with 1 bullish, 2 somewhat bullish, and 6 indifferent. The average 12-month price target for the company is $35.89, a 17.17% decrease from the previous average of $43.33.
October 02, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Mixed analyst ratings and a decreased price target could impact Tandem Diabetes Care's stock price.
Analyst ratings can significantly influence investor sentiment and stock price. The mixed ratings and decreased price target for TNDM suggest potential downward pressure on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100